Central effects of estradiol in the regulation of food intake, body weight, and adiposity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 1-3, 2010, Pages 65-73

  Brown, L M ^a   Clegg, D J ^b  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Estradiol; Fat deposition; Food intake; Neuropeptides; Obesity; Sex differences

Indexed keywords

CHOLECYSTOKININ; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GHRELIN; INSULIN; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; SEROTONIN; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; MELANIN; MELANIN-CONCENTRATING HORMONE;

BODY FAT DISTRIBUTION; BODY WEIGHT; CANCER RISK; CARDIOVASCULAR DISEASE; FOOD INTAKE; HORMONE RELEASE; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; MENOPAUSE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REGULATORY MECHANISM; REVIEW; SEX DIFFERENCE; ANIMAL; EATING; FEMALE; MALE; MOUSE; PHYSIOLOGY; RAT; SEXUAL DEVELOPMENT;

ADIPOSITY; ANIMALS; BODY FAT DISTRIBUTION; BODY WEIGHT; CHOLECYSTOKININ; EATING; ESTRADIOL; FEMALE; GHRELIN; HUMANS; HYPOTHALAMIC HORMONES; INSULIN; LEPTIN; MALE; MELANINS; MICE; NEUROPEPTIDE Y; PITUITARY HORMONES; RATS; RECEPTORS, ESTROGEN; SEROTONIN; SEX CHARACTERISTICS;

EID: 77956257843     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.12.005     Document Type: Review

References (192)

1. Geary N. Estradiol, CCK and satiation. Peptides 2001, 22(8):1251-1263.
2. Hrupka B.J., Smith G.P., Geary N. Hypothalamic implants of dilute estradiol fail to reduce feeding in ovariectomized rats. Physiol. Behav. 2002, 77(2-3):233-241.
3. Geary N. The estrogenic inhibition of eating. Handbook of Behavioral Neuroscience 2004, 304-343. Springer, New York. E.M. Stricker, S.C. Woods (Eds.).
4. Drewett R.F. Sexual behaviour and sexual motivation in the female rat. Nature 1973, 242(5398):476-477.
5. Asarian L., Geary N. Modulation of appetite by gonadal steroid hormones. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2006, 361(1471):1251-1263.
6. Santollo J., Eckel L.A. Estradiol decreases the orexigenic effect of neuropeptide Y, but not agouti-related protein, in ovariectomized rats. Behav. Brain Res. 2008, 191(2):173-177.
7. Messina M.M, Boersma G., Overton J.M., Eckel L.A. Estradiol decreases the orexigenic effect of melanin-concentrating hormone in ovariectomized rats. Physiol. Behav. 2006, 88(4-5):523-528.
8. Geary N., Lovejoy J. Sex differences in energy metabolism, obesity and eating behavior. Sex Differences in the Brain: From Genes to Behavior 2007, Oxford University Press, New York. K.J.B. Jill, B. Becker, N. Geary, E. Hampson, J.P. Herman, E. Young (Eds.).
9. Kannel W.B., Cupples L.A., Ramaswami R., Stokes J., Kreger B.E., Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham study. J. Clin. Eipidemiol. 1991, 44:183-190.
10. Lee C.G., Carr M.C., Murdoch S.J., Mitchell E., Woods N.F., Wener M.H., Chandler W.L., Boyko E.J., Brunzell J.D. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J. Clin. Endocrinol. Metab. 2009, 94(4):1104-1110.
11. Despres J.P Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993, 9(5):452-459.
12. Krotkiewski M., Bjorntorp P., Sjostrom L., Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 1983, 72(3):1150-1162.
13. Poehlman E.T., Toth M.J., Gardner A.W. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann. Intern. Med. 1995, 123(9):673-675.
14. Bouchard C., Despres J.P., Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr. Rev. 1993, 14(1):72-93.
15. Crandall D.L., Busler D.E., Novak T.J., Weber R.V., Kral J.G. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochem. Biophys. Res. Commun. 1998, 248(3):523-526.
16. Lu S.F., McKenna S.E., Cologer-Clifford A., Nau E.A., Simon N.G. Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology 1998, 139(4):1594-1601.
17. Bjorntorp P. Hormonal control of regional fat distribution. Hum. Reprod. 1997, 12(Suppl. 1):21-25.
18. Yu I.C., Lin H.Y., Liu N.C., Wang R.S., Sparks J.D., Yeh S., Chang C. Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology 2008, 149(5):2361-2368.
19. Clegg D.J., Brown L.M., Woods S.C., Benoit S.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006, 55(4):978-987.
20. Matelski H., Greene R., Huberman M., Lokich J., Zipoli T. Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancer. Am. J. Clin. Oncol. 1985, 8(2):128-133.
21. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(12):5925-5930.
22. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(23):12729-12734.
23. Musatov S., Chen W., Pfaff D.W., Mobbs C.V., Yang X.J., Clegg D.J., Kaplitt M.G., Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(7):2501-2506.
24. Schomberg D.W., Couse J.F., Mukherjee A., Lubahn D.B., Sar M., Mayo K.E., Korach K.S. Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology 1999, 140(6):2733-2744.
25. McEwen B.S., Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 1999, 20(3):279-307.
26. Ohlsson C., Hellberg N., Parini P., Vidal O., Bohlooly M., Rudling M., Lindberg M.K., Warner M., Angelin B., Gustafsson J.A. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha- deficient male mice. Biochem. Biophys. Res. Commun. 2000, 278(3):640-645.
27. Merchenthaler I., Lane M.V., Numan S., Dellovade T.L. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. J. Comp. Neurol. 2004, 473(2):270-291.
28. Osterlund M., Kuiper G.G., Gustafsson J.A., Hurd Y.L. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res. Mol. Brain Res. 1998, 54(1):175-180.
29. Shima N., Yamaguchi Y., Yuri K. Distribution of estrogen receptor beta mRNA-containing cells in ovariectomized and estrogen-treated female rat brain. Anat. Sci. Int. 2003, 78(2):85-97.
30. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 1990, 294(1):76-95.
31. Simonian S.X., Herbison A.E. Differential expression of estrogen receptor alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular nucleus. J. Neuroendocrinol. 1997, 9(11):803-806.
32. Voisin D.L., Simonian S.X., Herbison A.E. Identification of estrogen receptor-containing neurons projecting to the rat supraoptic nucleus. Neuroscience 1997, 78(1):215-228.
33. Wilkinson H.A., Dahllund J., Liu H., Yudkovitz J., Cai S.J., Nilsson S., Schaeffer J.M., Mitra S.W. Identification and characterization of a functionally distinct form of human estrogen receptor beta. Endocrinology 2002, 143(4):1558-1561.
34. Butera P.C., Beikirch R.J. Central implants of diluted estradiol: independent effects on ingestive and reproductive behaviors of ovariectomized rats. Brain Res. 1989, 491(2):266-273.
35. Palmer K., Gray J.M. Central vs. peripheral effects of estrogen on food intake and lipoprotein lipase activity in ovariectomized rats. Physiol. Behav. 1986, 37(1):187-189.
36. Kahn B.B., Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106(4):473-481.
37. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 112(12):1785-1788.
38. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115(5):1111-1119.
39. Dhar M.S., Sommardahl C.S., Kirkland T., Nelson S., Donnell R., Johnson D.K., Castellani L.W. Mice heterozygous for Atp10c, a putative amphipath, represent a novel model of obesity and type 2 diabetes. J. Nutr. 2004, 134(4):799-805.
40. Gallou-Kabani C., Vige A., Gross M.S., Boileau C., Rabes J.P., Fruchart-Najib J., Jais J.P., Junien C. Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods. Am. J. Physiol. Endocrinol. Metab. 2007, 292(4):E1095-1100.
41. Payette C., Blackburn P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., Despres J.P., Couillard C. Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism 2009.
42. Ghisletti S., Meda C., Maggi A., Vegeto E. 17Beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol. Cell. Biol. 2005, 25(8):2957-2968.
43. Turgeon J.L., Carr M.C., Maki P.M., Mendelsohn M.E., Wise P.M. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr. Rev. 2006, 27(6):575-605.
44. Vegeto E., Belcredito S., Etteri S., Ghisletti S., Brusadelli A., Meda C., Krust A., Dupont S., Ciana P., Chambon P., Maggi A. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(16):9614-9619.
45. Vegeto E., Bonincontro C., Pollio G., Sala A., Viappiani S., Nardi F., Brusadelli A., Viviani B., Ciana P., Maggi A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 2001, 21(6):1809-1818.
46. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell. Biol. 1995, 15(9):4971-4979.
47. Kalaitzidis D., Gilmore T.D. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab 2005, 16(2):46-52.
48. Chadwick C.C., Chippari S., Matelan E., Borges-Marcucci L., Eckert A.M., Keith J.C., Albert L.M., Leathurby Y., Harris H.A., Bhat R.A., Ashwell M., Trybulski E., Winneker R.C., Adelman S.J., Steffan R.J., Harnish D.C. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(7):2543-2548.
49. Harris H.A., Albert L.M., Leathurby Y., Malamas M.S., Mewshaw R.E., Miller C.P., Kharode Y.P., Marzolf J., Komm B.S., Winneker R.C., Frail D.E., Henderson R.A., Zhu Y., Keith J.C. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003, 144(10):4241-4249.
50. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116(11):3015-3025.
51. Wise P.M. Estrogens and neuroprotection. Trends Endocrinol. Metab. 2002, 13(6):229-230.
52. Maggi A., Ciana P., Belcredito S., Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu. Rev. Physiol. 2004, 66:291-313.
53. Pozzi S., Benedusi V., Maggi A., Vegeto E. Estrogen action in neuroprotection and brain inflammation. Ann. NY Acad. Sci. 2006, 1089:302-323.
54. Vegeto E., Belcredito S., Ghisletti S., Meda C., Etteri S., Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006, 147(5):2263-2272.
55. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115(1):427-429.
56. Stanley B.G., Kyrkouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986, 7:1189-1192.
57. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 1999, 20(1):68-100.
58. Wade G.N., Gray J.M., Bartness T.J. Gonadal influences on adiposity. Int. J. Obes. 1985, 9(Suppl. 1):83-92.
59. Bonavera J.J., Dube M.G., Kalra P.S., Kalra S.P. Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. Endocrinology 1994, 134(6):2367-2370.
60. Titolo D., Cai F., Belsham D.D. Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) alpha to ERbeta in clonal hypothalamic neurons. Mol. Endocrinol. (Baltimore, MD) 2006, 20(9):2080-2092.
61. Clegg D.J., Benoit S.C., Fisher M.E., Barrera J.G., Seeley R.J., Woods S.C. Sex hormones determine body fat distribution and sensitivity to adiposity signals. Appetite 2003, 40:324.
62. Ainslie D.A., Morris M.J., Wittert G., Turnbull H., Proietto J., Thorburn A.W. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int. J. Obes. Relat. Metab. Disord. 2001, 25(11):1680-1688.
63. Akabayashi A., Watanabe Y., Wahlestedt C., McEwen B.S., Paez X., Leibowitz S.F. Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res. 1994, 665(2):201-212.
64. Pelleymounter M.A, Baker M.B., McCaleb M. Does estradiol mediate leptin's effects on adiposity and body weight?. Am. J. Physiol. 1999, 276(5 Pt 1):E955-963.
65. Acosta-Martinez M., Horton T., Levine J.E. Estrogen receptors in neuropeptide Y neurons: at the crossroads of feeding and reproduction. Trends Endocrinol. Metab. 2007, 18(2):48-50.
66. Bauer-Dantoin A.C., Urban J.H., Levine J.E. Neuropeptide Y gene expression in the arcuate nucleus is increased during preovulatory luteinizing hormone surges. Endocrinology 1992, 131(6):2953-2958.
67. Hill J.W., Urban J.H., Xu M., Levine J.E. Estrogen induces neuropeptide Y (NPY) Y1 receptor gene expression and responsiveness to NPY in gonadotrope-enriched pituitary cell cultures. Endocrinology 2004, 145(5):2283-2290.
68. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402(6762):656-660.
69. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., Van der Ploeg L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (New York, NY) 1996, 273(5277):974-977.
70. Kojima M., Kangawa K. Ghrelin: structure and function. Physiol. Rev. 2005, 85(2):495-522.
71. Clegg D.J., Brown L.M., Zigman J.M., Kemp C.J., Strader A.D., Benoit S.C., Woods S.C., Mangiaracina M., Geary N. Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007, 56(4):1051-1058.
72. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001, 409(6817):194-198.
73. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806):908-913.
74. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50(11):2540-2547.
75. Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschop M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 2001, 142(10):4163-4169.
76. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 2001, 86(12):5992.
77. Arnold M., Mura A., Langhans W., Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J. Neurosci. 2006, 26(43):11052-11060.
78. Davidson T.L., Kanoski S.E., Tracy A.L., Walls E.K., Clegg D., Benoit S.C. The interoceptive cue properties of ghrelin generalize to cues produced by food deprivation. Peptides 2005, 26(9):1602-1610.
79. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., Seeley R.J., Lowell B.B., Elmquist J.K. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 2005, 115(12):3564-3572.
80. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000, 141(12):4797-4800.
81. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 50(11):2438-2443.
82. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001, 50(2):227-232.
83. Horvath T.L, Diano S., Tschop M. Ghrelin in hypothalamic regulation of energy balance. Curr. Top. Med. Chem. 2003, 3(8):921-927.
84. Naleid A.M., Grace M.K., Cummings D.E., Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26(11):2274-2279.
85. Willesen M.G., Kristensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999, 70(5):306-316.
86. Faulconbridge L.F., Cummings D.E., Kaplan J.M., Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes 2003, 52(9):2260-2265.
87. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37(4):649-661.
88. Currie P.J., Mirza A., Fuld R., Park D., Vasselli J.R. Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289(2):R353-R358.
89. Thammacharoen S., Lutz T.A., Geary N., Asarian L. Hindbrain administration of estradiol inhibits feeding and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats. Endocrinology 2008, 149(4):1609-1617.
90. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L., Vale W., Sawchenko P.E. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 1992, 319(2):218-245.
91. Vaughan J.M., Fischer W.H., Hoeger C., Rivier J., Vale W. Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 1989, 125(3):1660-1665.
92. Pissios P., Bradley R.L., Maratos-Flier E. Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions. Endocr. Rev. 2006, 27(6):606-620.
93. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J., Mathes W.F., Przypek R., Kanarek R., Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380(6571):243-247.
94. Rossi M., Choi S.J., O'Shea D., Miyoshi T., Ghatei M.A., Bloom S.R. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 1997, 138(1):351-355.
95. Shimada M., Tritos N., Lowell B., Flier J., Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998, 396(Dec 17):670-674.
96. Alon T., Friedman J.M. Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. J. Neurosci. 2006, 26(2):389-397.
97. Broberger C., De Lecea L., Sutcliffe J.G., Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 1998, 402:460-474.
98. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., Flier J.S., Saper C.B., Elmquist J.K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999, 23(4):775-786.
99. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., Elmquist J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998, 402(4):442-459.
100. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004, 116:337-350.
101. Schwartz M.W., Woods S.C., Porte D.J., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
102. Zigman J.M., Elmquist J.K. Minireview: From anorexia to obesity-the yin and yang of body weight control. Endocrinology 2003, 144(9):3749-3756.
103. Georgescu D., Sears R.M., Hommel J.D., Barrot M., Bolanos C.A., Marsh D.J., Bednarek M.A., Bibb J.A., Maratos-Flier E., Nestler E.J., DiLeone R.J. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci. 2005, 25(11):2933-2940.
104. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 1997, 388(4):507-525.
105. Murray J.F., Baker B.I., Levy A., Wilson C.A. The influence of gonadal steroids on pre-pro melanin-concentrating hormone mRNA in female rats. J. Neuroendocrinol. 2000, 12(1):53-59.
106. Morton G.J., Mystkowski P., Matsumoto A.M., Schwartz M.W. Increased hypothalamic melanin concentrating hormone gene expression during energy restriction involves a melanocortin-independent, estrogen-sensitive mechanism. Peptides 2004, 25(4):667-674.
107. Tritos N.A, Segal-Lieberman G., Vezeridis P.S., Maratos-Flier E. Estradiol-induced anorexia is independent of leptin and melanin-concentrating hormone. Obes. Res. 2004, 12(4):716-724.
108. Hervieu G.J., Cluderay J.E., Harrison D., Meakin J., Maycox P., Nasir S., Leslie R.A. The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eur. J. Neurosci. 2000, 12(4):1194-1216.
109. Muschamp J.W, Hull E.M. Melanin concentrating hormone and estrogen receptor-alpha are coexstensive but not coexpressed in cells of male rat hypothalamus. Neurosci. Lett. 2007, 427(3):123-126.
110. Smith G.P. The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience. Nutrition 2000, 16:814-820.
111. Geary N., Asarian L., Korach K.S., Pfaff D.W., Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 2001, 142(11):4751-4757.
112. Kennedy G.C. The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. Lond. (Biol.) 1953, 140:579-592.
113. Baskin D.G., Figlewicz D.P., Woods S.C., Porte D., Dorsa D.M. Insulin in the brain. Annu. Rev. Physiol. 1987, 49:335-347.
114. Woods S.C. Insulin and the brain: a mutual dependency. Prog. Psychobiol. Physiol. Psychol. 1996, 16:53-81.
115. Bagdade J.D., Bierman E.L., Porte D. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. Clin. Invest. 1967, 46:1549-1557.
116. Polonsky K.S., Given B.D., Hirsch L., Shapiro E.T., Tillil H., Beebe C., Galloway J.A., Frank B.H., Karrison T., Van-Cauter E. Quantitative study of insulin secretion and clearance in normal and obese subjects. J. Clin. Invest. 1988, 81:435-441.
117. Polonsky K.S., Given E., Carter V. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J. Clin. Invest. 1988, 81:442-448.
118. Woods S.C., Decke E., Vasselli J.R. Metabolic hormones and regulation of body weight. Psychol. Rev. 1974, 81(1):26-43.
119. Werther G.A., Hogg A., Oldfield B.J., McKinley M.J., Figdor R., Allen A.M., Mendelsohn F.A. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 1987, 121(4):1562-1570.
120. Folli F., Saad M.J., Kahn C.R. Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance. Acta Diabetol. 1996, 33(3):185-192.
121. Hill J.M., Lesniak M.A., Pert C.B., Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 1986, 17:1127-1138.
122. Schwartz M.W., Porte D. Diabetes, obesity, and the brain. Science (New York, NY) 2005, 307(5708):375-379.
123. Niswender K.D, Morrison C.D., Clegg D.J., Olson R., Baskin D.G., Myers M.G., Seeley R.J., Schwartz M.W. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003, 52(2):227-231.
124. Niswender K.D., Schwartz M.W. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front. Neuroendocrinol. 2003, 24:1-10.
125. Benoit S.C., Air E.L., Coolen L.M., Strauss R., Jackman A., Clegg D.J., Seeley R.J., Woods S.C. The catabolic action of insulin in the brain is mediated by melanocortins. J. Neurosci. 2002, 22(20):9048-9052.
126. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372(6505):425-432.
127. Banks W.A., Kastin A.J., Huang W.E.A. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
128. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., Baskin D.G. Identification of hypothalmic targets of leptin action. J. Clin. Invest. 1996, 98:1101-1106.
129. Clegg D.J., Riedy C.A., Smith K.A., Benoit S.C., Woods S.C. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 2003, 52(3):682-687.
130. Ahima R.S., Kelly J., Elmquist J.K., Flier J.S. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 1999, 140(11):4923-4931.
131. Seeley R.J., Woods S.C. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat. Rev. Neurosci. 2003, 4(11):901-909.
132. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999, 22:221-232.
133. Morton G.J., Niswender K.D., Rhodes C.J., Myers M.G., Blevins J.E., Baskin D.G., Schwartz M.W. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology 2003, 144(5):2016-2024.
134. Woods S.C., Schwartz M.W., Baskin D.G., Seeley R.J. Food intake and the regulation of body weight. Ann. Rev. Psychol. 2000, 51:255-277.
135. Balthasar N., Coppari R., McMinn J., Liu S.M., Lee C.E., Tang V., Kenny C.D., McGovern R.A., Chua S.C., Elmquist J.K., Lowell B.B. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004, 42(6):983-991.
136. Demerath E.W., Towne B., Wisemandle W., Blangero J., Chumlea W.C., Siervogel R.M. Serum leptin concentration, body composition, and gonadal hormones during puberty. Int. J. Obes. Relat. Metab. Disord. 1999, 23(7):678-685.
137. Shimizu H., Shimomura Y., Nakanishi Y., Futawatari T., Ohtani K., Sato N., Mori M. Estrogen increases in vivo leptin production in rats and human subjects. J. Endocrinol. 1997, 154(2):285-292.
138. Wu-Peng S., Rosenbaum M., Nicolson M., Chua S.C., Leibel R.L. Effects of exogenous gonadal steroids on leptin homeostasis in rats. Obes. Res. 1999, 7(6):586-592.
139. Machinal F., Dieudonne M.N., Leneveu M.C., Pecquery R., Giudicelli Y. In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 1999, 140(4):1567-1574.
140. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Flier-Maratos E., Flier J.S. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
141. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., Muir C., Sanker S., Moriarty A., Moore K.J., Smutko J.S., Mays G.G., Woolf E.A., Monroe C.A., Tepper R.I. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
142. Seeley R.J., van Dijk G., Campfield L.A., Smith F.J., Burn P., Nelligan J.A., Bell S.M., Baskin D.G., Woods S.C., Schwartz M.W. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm. Metab. Res. 1996, 28(12):664-668.
143. Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., Duyk G.M., Tepper R.I., Morgenstern J.P. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84(3):491-495.
144. Mitra S.W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H.A., Hayashi S., Pfaff D.W., Ogawa S., Rohrer S.P., Schaeffer J.M., McEwen B.S., Alves S.E. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144(5):2055-2067.
145. Diano S., Kalra S.P., Horvath T.L. Leptin receptor immunoreactivity is associated with the Golgi apparatus of hypothalamic neurons and glial cells. J. Neuroendocrinol. 1998, 10(9):647-650.
146. Bennett P.A., Lindell K., Wilson C., Carlsson L.M., Carlsson B., Robinson I.C. Cyclical variations in the abundance of leptin receptors, but not in circulating leptin, correlate with NPY expression during the oestrous cycle. Neuroendocrinology 1999, 69(6):417-423.
147. Lindell K., Bennett P.A., Itoh Y., Robinson I.C., Carlsson L.M., Carlsson B. Leptin receptor 5' untranslated regions in the rat: relative abundance, genomic organization and relation to putative response elements. Mol. Cell Endocrinol. 2001, 172(1-2):37-45.
148. Clegg D.J., Benoit S.C., Barrera J.G., Woods S.C. Estrogen mediates body fat distribution and brain sensitivity to adiposity signals. Diabetes 2003, 52(Suppl. 1).
149. Elmquist J.K., Ahima R.S., Elias C.F., Flier J.S., Saper C.B. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:741-746.
150. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 1998, 395(4):535-547.
151. Elmquist J.K., Maratos-Flier E., Saper C.B., Flier J.S. Unraveling the central nervous system pathways underlying responses to leptin. Nat. Neurosci. 1998, 1:445-450.
152. Bennett P.A., Lindell K., Karlsson C., Robinson I.C., Carlsson L.M., Carlsson B. Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen. Neuroendocrinology 1998, 67(1):29-36.
153. Kimura M., Irahara M., Yasui T., Saito S., Tezuka M., Yamano S., Kamada M., Aono T. The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain. Biochem. Biophys. Res. Commun. 2002, 290(4):1349-1353.
154. Simansky K. Serotonin and the structure of satiation. Satiation: From Gut to Brain 1998, 217-262. Oxford University Press, New York. G. Smith (Ed.).
155. Rivera H.M., Eckel L.A. The anorectic effect of fenfluramine is increased by estradiol treatment in ovariectomized rats. Physiol. Behav. 2005, 86(3):331-337.
156. Salamanca S., Uphouse L. Estradiol modulation of the hyperphagia induced by the 5-HT1A agonist, 8-OH-DPAT. Pharmacol. Biochem. Behav. 1992, 43(3):953-955.
157. Uphouse L., Salamanca S., Caldarola-Pastuszka M. Gender and estrous cycle differences in the response to the 5-HT1A agonist 8-OH-DPAT. Pharmacol. Biochem. Behav. 1991, 40(4):901-906.
158. Rivera H.M., Oberbeck D.R., Kwon B., Houpt T.A., Eckel L.A. Estradiol increases Pet-1 and serotonin transporter mRNA in the midbrain raphe nuclei of ovariectomized rats. Brain Res. 2009, 1259:51-58.
159. McQueen J.K., Wilson H., Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res. Mol. Brain Res. 1997, 45(1):13-23.
160. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res. Mol. Brain Res. 1999, 73(1-2):119-128.
161. Petrov T., Krukoff T.L., Jhamandas J.H. The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study. J. Comp. Neurol. 1992, 318(1):18-26.
162. Peyron C., Petit J.M., Rampon C., Jouvet M., Luppi P.H. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 1998, 82(2):443-468.
163. Fumeron F., Betoulle D., Aubert R., Herbeth B., Siest G., Rigaud D. Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol. Psychiatry 2001, 6(1):9-10.
164. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66(6):2621-2624.
165. Moran T.H. Gut peptides in the control of food intake. Int. J. Obes. (Lond.) 2009, 33(Suppl. 1):S7-S10.
166. Cox J.E. Cholecystokinin satiety involves CCKA receptors perfused by the superior pancreaticoduodenal artery. Am. J. Physiol. 1998, 274(5 Pt 2):R1390-R1396.
167. Smith G., Gibbs J. The satiating effects of cholecystokinin and bombesin-like peptides. Satiation from Gut to Brain 1998, 97-125. Oxford University Press, New York. G. Smith (Ed.).
168. Beglinger C., Degen L., Matzinger D., D'Amato M., Drewe J. Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am. J. Physiol. 2001, 280:R1149-R1154.
169. Moran T.H., Ameglio P.J., Peyton H.J., Schwartz G.J., McHugh P.R. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am. J. Physiol. 1993, 265:R620-R624.
170. Huang Y.S., Doi R., Chowdhury P., Pasley J.N., Nishikawa M., Huang T.J., Rayford P.L. Effect of cholecystokinin on food intake at different stages of the estrous cycle in female rats. J. Assoc. Acad. Minor Phys. 1993, 4(2):56-58.
171. Asarian L., Geary N. Cyclic estradiol treatment phasically potentiates endogenous cholecystokinin's satiating action in ovariectomized rats. Peptides 1999, 20(4):445-450.
172. Asarian L., Geary N. Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats. Endocrinology 2007, 148(12):5656-5666.
173. Eckel L.A., Geary N. Endogenous cholecystokinin's satiating action increases during estrus in female rats. Peptides 1999, 20(4):451-456.
174. Moran T.H., Ameglio P.J., Schwartz G.J., McHugh P.R. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am. J. Physiol. 1992, 262(1 Pt 2):R46-R50.
175. Reidelberger R.D. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats. Am. J. Physiol. 1992, 263(6 Pt 2):R1354-1358.
176. Moran T.H., Norgren R., Crosby R.J., McHugh P.R. Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res. 1990, 526(1):95-102.
177. Geary N., Smith G.P., Corp E.S. The increased satiating potency of CCK-8 by estradiol is not mediated by upregulation of NTS CCK receptors. Brain Res. 1996, 719(1-2):179-186.
178. Linden A., Uvnas-Moberg K., Forsberg G., Bednar I., Sodersten P. Involvement of cholecystokinin in food intake: III. Oestradiol potentiates the inhibitory effect of cholecystokinin octapeptide on food intake in ovariectomized rats. J. Neuroendocrinol. 1990, 2(6):797-801.
179. Butera P.C., Bradway D.M., Cataldo N.J. Modulation of the satiety effect of cholecystokinin by estradiol. Physiol. Behav. 1993, 53(6):1235-1238.
180. Geary N., Asarian L. Cyclic estradiol treatment normalizes body weight and test meal size in ovariectomized rats. Physiol. Behav. 1999, 67(1):141-147.
181. DiNardo L.A., Travers J.B. Distribution of fos-like immunoreactivity in the medullary reticular formation of the rat after gustatory elicited ingestion and rejection behaviors. J. Neurosci. 1997, 17(10):3826-3839.
182. Eckel L.A., Geary N. Estradiol treatment increases feeding-induced c-Fos expression in the brains of ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281(3):R738-746.
183. Rinaman L., Baker E.A., Hoffman G.E., Stricker E.M., Verbalis J.G. Medullary c-Fos activation in rats after ingestion of a satiating meal. Am. J. Physiol. 1998, 275:R262-R268.
184. Park T.H., Carr K.D. Neuroanatomical patterns of fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline- and naltrexone-treated rats. Brain Res. 1998, 805(1-2):169-180.
185. Emond M.H., Weingarten H.P. Fos-like immunoreactivity in vagal and hypoglossal nuclei in different feeding states: a quantitative study. Physiol. Behav. 1995, 58(3):459-465.
186. Fraser K.A., Davison J.S. Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release. Am. J. Physiol. 1993, 265(1 Pt 2):R235-239.
187. Rinaman L., Hoffman G.E., Dohanics J., Le W.W., Stricker E.M., Verbalis J.G. Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats. J. Comp. Neurol. 1995, 360:246-256.
188. Li B.H., Rowland N.E. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain. Regul. Pept. 1994, 50:223-233.
189. Rinaman L., Verbalis J.G., Stricker E.M., Hoffman G.E. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J. Comp. Neurol. 1993, 338(4):475-490.
190. Olson B.R., Hoffman G.E., Sved A.F., Stricker E.M., Verbalis J.G. Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex. Brain Res. 1992, 569(2):238-248.
191. Chen D.Y., Deutsch J.A., Gonzalez M.F., Gu Y. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci. Lett. 1993, 149(1):91-94.
192. Eckel L.A., Houpt T.A., Geary N. Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283(6):R1378-1385.